Header Logo

Connection

FILIP JANKU to MAP Kinase Kinase 1

Back to Details
This is a "connection" page, showing publications FILIP JANKU has written about MAP Kinase Kinase 1.
FILIP JANKU
Connection Strength
0.150
MAP Kinase Kinase 1
  1. Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials. Oncotarget. 2014 Oct 15; 5(19):8937-46.
    View in: PubMed
    Score: 0.118
  2. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov. 2016 Feb; 6(2):154-65.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.